niacinamide has been researched along with dihydronicotinamide in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (37.50) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hajdu, J; Sigman, DS | 1 |
| Carelli, I; Casini, A; Mondelli, R; Ragg, E; Scaglioni, L; Tortorella, S | 1 |
| Murdock, GL; Pineda, JA; Warren, JC; Watson, RJ | 1 |
| Abdelim, AM; Bodor, N | 1 |
| Kaiser, ET; Lawrence, DS | 1 |
| Bright, HJ; Porter, DJ | 1 |
| Ballou, DP; Gatti, D; Massey, V; Ortiz-Maldonado, M | 1 |
| Osborne, MJ; Wright, PE | 1 |
| Cheng, JP; Liu, Y; Zhao, BJ; Zhu, XQ | 1 |
| Baccanari, DP; Chan, JH; Hardman, KD; Hong, JS; Howard, AJ; Kuyper, LF; Stewart, D; Tansik, RL; Whitlow, M | 1 |
| Cao, L; Cheng, JP; Liu, Y; Lu, JY; Wang, JS; Yang, Y; Zhu, XQ | 1 |
| LIAO, S; WILLIAMS-ASHMAN, HG | 1 |
| DAHL, C; MAHLER, HR | 1 |
| DALZIEL, K | 1 |
| ALIVISTOTOS, SG; WILLIAMS-ASHMAN, HG | 1 |
| KESSELRING, K; SIEBERT, G | 1 |
| Caraher, MC; Gill, JR; Megarity, CF; Nolan, KA; Stratford, IJ; Timson, DJ | 1 |
| Bisenieks, E; Duburs, G; Gall Troselj, K; Krauze, A; Poikans, J; Velena, A; Zarkovic, N | 1 |
| Bruno, S; Campanini, B; Dellafiora, L; Faggiano, S; Marchesani, F; Margiotta, M; Mozzarelli, A | 1 |
| Li, YY; Meng, YY; Wang, JY; Xu, WQ; Yang, FJ; Zhang, Y; Zhang, YR | 1 |
| Chen, MW; Li, X; Zhao, ZB; Zhao, ZK; Zhou, YG | 1 |
| Sauve, AA; Yang, Y; Zhang, G; Zhang, N | 1 |
| Chanan-Khan, AA; Chini, CCS; Chini, EN; Gomez, LS; Hayat, F; Kashyap, S; Mazdeh, DZ; Migaud, ME; Paulus, A; Peclat, TR; Warner, GM; Zeidler, JD | 1 |
| Cantó, C; Ciarlo, E; Giner, MP; Giroud-Gerbetant, J; Hayat, F; Joffraud, M; Migaud, ME; Moco, S; Rumpler, M; Sanchez-Garcia, JL | 1 |
1 review(s) available for niacinamide and dihydronicotinamide
| Article | Year |
|---|---|
1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.
Topics: Amlodipine; Animals; Antioxidants; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cattle; Dihydropyridines; Epithelial Cells; Humans; Hydrogen; Lipoproteins, LDL; Mice; Microsomes; Mitochondria; Niacinamide; Nifedipine; Nitrobenzenes; Oxidants; Oxidative Stress; Piperazines | 2016 |
23 other study(ies) available for niacinamide and dihydronicotinamide
| Article | Year |
|---|---|
Model dehydrogenase reactions. Catalysis of dihydronicotinamide reductions by noncovalent interactions.
Topics: Acridines; Catalysis; Chemical Phenomena; Chemistry; Chloranil; Kinetics; NAD; Niacinamide; Oxidation-Reduction | 1977 |
1H-, 13C-, 31P-NMR studies and conformational analysis of NADP+, NADPH coenzymes and of dimers from electrochemical reduction of NADP+.
Topics: Macromolecular Substances; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; NADP; Niacinamide; Oxidation-Reduction | 1991 |
Stereospecificity of hydrogen transfer between progesterone and cofactor by human placental estradiol-17 beta dehydrogenase.
Topics: Binding Sites; Biological Transport; Catalysis; Chromatography, High Pressure Liquid; Estradiol; Estradiol Dehydrogenases; Glutamate Dehydrogenase; Humans; Hydrogen; NADP; Niacinamide; Placenta; Progesterone; Substrate Specificity | 1990 |
Improved delivery through biological membranes XX: Nicotinamide----dihydronicotinamide based ester-linked redox carrier systems.
Topics: Animals; Body Fluids; Brain; Chemistry, Pharmaceutical; Female; Hydrolysis; In Vitro Techniques; Kidney; Kinetics; Membranes; Niacinamide; Oxidation-Reduction; Rats; Rats, Inbred Strains; Testosterone | 1986 |
Chemical mutation of enzyme active sites.
Topics: Anaerobiosis; Binding Sites; Catalysis; Chemical Phenomena; Chemistry; Chymotrypsin; Enzymes; Flavins; Kinetics; NAD; Niacinamide; Oxidation-Reduction; Papain; Stereoisomerism; Toluene | 1984 |
Oxidation of dihydronicotinamides by flavin in enzyme and model reactions. Old yellow enzyme and lumiflavin.
Topics: Aerobiosis; Flavins; Kinetics; Models, Biological; NAD; NADH, NADPH Oxidoreductases; NADP; NADPH Dehydrogenase; Niacinamide; Oxidation-Reduction; Saccharomyces cerevisiae | 1980 |
Structure-function correlations of the reaction of reduced nicotinamide analogues with p-hydroxybenzoate hydroxylase substituted with a series of 8-substituted flavins.
Topics: 4-Hydroxybenzoate-3-Monooxygenase; Crystallography, X-Ray; Flavin-Adenine Dinucleotide; Flavins; NADP; Niacinamide; Oxidation-Reduction; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Substrate Specificity | 1999 |
Anisotropic rotational diffusion in model-free analysis for a ternary DHFR complex.
Topics: Anisotropy; Diffusion; Folic Acid; Models, Chemical; Models, Molecular; Motion; Niacinamide; Nuclear Magnetic Resonance, Biomolecular; Tetrahydrofolate Dehydrogenase | 2001 |
An old but simple and efficient method to elucidate the oxidation mechanism of NAD(P)H model 1-Aryl-1,4-dihydronicotinamides by cations 2-methyl-5-nitroisoquinolium, tropylium, and xanthylium in aqueous solution.
Topics: Cycloheptanes; Heterocyclic Compounds, 3-Ring; Kinetics; Models, Chemical; NAD; NADP; Niacinamide; Oxidation-Reduction; Quinolinium Compounds; Solutions; Structure-Activity Relationship; Thermodynamics | 2001 |
X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor.
Topics: Candida albicans; Crystallography, X-Ray; Folic Acid Antagonists; Models, Molecular; NADP; Niacinamide; Quinazolines; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2001 |
Thermodynamics and kinetics of the hydride-transfer cycles for 1-aryl-1,4-dihydronicotinamide and its 1,2-dihydroisomer.
Topics: Electron Transport; Hydrogen; Kinetics; Models, Chemical; Molecular Structure; NAD; NADP; Niacinamide; Oxidation-Reduction; Protons; Pyridines; Spectrophotometry, Ultraviolet; Stereoisomerism; Structure-Activity Relationship; Thermodynamics | 2003 |
Enzymatic oxidation of some non-phosphorylated derivatives of dihydronicotinamide.
Topics: Niacin; Niacinamide; Nicotinic Acids; Oxidation-Reduction | 1961 |
Some oxidation reactions of N-benzyl-1, 4-dihydronicotinamide.
Topics: Niacin; Niacinamide; Nicotinic Acids; Oxidation-Reduction | 1961 |
Some observations on the preparation and properties of dihydronicotinamide-adenine dinucleotide.
Topics: Adenine; NAD; Niacinamide; Nucleosides; Nucleotides | 1962 |
SEROTONIN-MEDIATED OXIDATION OF DIHYDRONICOTINAMIDE DERIVATIVES BY CYTOCHROME C.
Topics: Cytochromes; Cytochromes c; Electron Transport; Manganese; NAD; Niacinamide; Oxidation-Reduction; Research; Serotonin; Spectrophotometry | 1964 |
[PROPERTIES OF DINUCLEOTIDE PYROPHOSPHATASE FROM RAT KIDNEY PARTICLES AND COENZYME PRODUCTS OF THE END PRODUCTS DIHYDRONICOTINAMIDE MONONUCLEOTIDE AND DIHYDRONICOTINAMIDE RIBOSIDE].
Topics: Adenine Nucleotides; Coenzymes; Kidney; NAD; Niacinamide; Nucleosides; Nucleotides; Pyrophosphatases; Rats; Research | 1964 |
The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties.
Topics: 2,6-Dichloroindophenol; Amino Acid Substitution; Dinitrocresols; Enzyme Inhibitors; Enzyme Stability; Humans; Isoenzymes; Kinetics; Niacinamide; Oxidation-Reduction; Polymorphism, Single Nucleotide; Proteolysis; Quinone Reductases; Resveratrol; Stilbenes | 2014 |
Human serine racemase is allosterically modulated by NADH and reduced nicotinamide derivatives.
Topics: Adenosine Triphosphate; Allosteric Site; Binding Sites; Humans; Inhibitory Concentration 50; Kinetics; NAD; NADP; Niacinamide; Protein Binding; Protein Structure, Tertiary; Racemases and Epimerases; Receptors, N-Methyl-D-Aspartate; Serine | 2016 |
Design and synthesis a mitochondria-targeted dihydronicotinamide as radioprotector.
Topics: Animals; Antioxidants; CHO Cells; Cricetinae; Cricetulus; Drug Design; Male; Mice, Inbred C57BL; Mitochondria; Niacinamide; Oxidative Stress; Radiation Injuries, Experimental; Radiation-Protective Agents; Reactive Oxygen Species | 2019 |
Biomimetic asymmetric reduction of benzoxazinones and quinoxalinones using ureas as transfer catalysts.
Topics: Benzoxazines; Biomimetic Materials; Catalysis; Cell Cycle Proteins; Coordination Complexes; Hydrogen Bonding; Models, Chemical; Molecular Conformation; NAD; Niacinamide; Oxidation-Reduction; Quinoxalines; Ruthenium; Substrate Specificity; Transcription Factors; Urea | 2020 |
NRH salvage and conversion to NAD
Topics: Adenosine Kinase; Animals; Cells, Cultured; Mice; NAD; Niacinamide; Phosphorylation | 2020 |
Dihydronicotinamide Riboside Is a Potent NAD
Topics: Cytokines; Glycosides; Macrophages; NAD; Niacinamide; Phenotype | 2022 |
Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD
Topics: Animals; Mammals; Mice; NAD; Niacinamide; Pyridinium Compounds | 2022 |